Long-term evolution of direct healthcare costs for inflammatory bowel diseases: a population-based study (2006-2015).

CONCLUSIONS: Over the past 10 years, the increased usage of anti-TNF agents has been the key driver of IBD-related healthcare costs. Long-term cost-cutting strategies for patients with CD are warranted. PMID: 30905222 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30905222?dopt=Abstract

Source: Scandinavian Journal of Gastroenterology - March 25, 2019 Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research